Clinical Trial Update: A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After Transplantation [Phase 1]

View source ↗

Summary

Mayo Clinic-sponsored Phase 1 pilot trial evaluating nitazoxanide (Alinia) to prevent recurrence of Hepatitis C after liver transplantation; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Alinia (Nitazoxanide)

Snippet

Sponsor: Mayo Clinic | Conditions: Hepatitis C Recurrence | Phase 1 | Status: COMPLETED